GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Avricore Health Inc (TSXV:AVCR) » Definitions » EV-to-Revenue

Avricore Health (TSXV:AVCR) EV-to-Revenue : 6.09 (As of May. 05, 2024)


View and export this data going back to 2001. Start your Free Trial

What is Avricore Health EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Avricore Health's enterprise value is C$15.09 Mil. Avricore Health's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was C$2.48 Mil. Therefore, Avricore Health's EV-to-Revenue for today is 6.09.

The historical rank and industry rank for Avricore Health's EV-to-Revenue or its related term are showing as below:

TSXV:AVCR' s EV-to-Revenue Range Over the Past 10 Years
Min: -10983.5   Med: 16.28   Max: 2788.11
Current: 6.09

During the past 13 years, the highest EV-to-Revenue of Avricore Health was 2788.11. The lowest was -10983.50. And the median was 16.28.

TSXV:AVCR's EV-to-Revenue is ranked worse than
71.11% of 225 companies
in the Medical Diagnostics & Research industry
Industry Median: 3.04 vs TSXV:AVCR: 6.09

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-05), Avricore Health's stock price is C$0.155. Avricore Health's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was C$0.03. Therefore, Avricore Health's PS Ratio for today is 5.96.


Avricore Health EV-to-Revenue Historical Data

The historical data trend for Avricore Health's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avricore Health EV-to-Revenue Chart

Avricore Health Annual Data
Trend Jun13 Jun14 Jun15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 261.76 47.91 222.11 110.83 17.24

Avricore Health Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23 Sep23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 49.18 17.33 17.24 8.58 7.49

Competitive Comparison of Avricore Health's EV-to-Revenue

For the Diagnostics & Research subindustry, Avricore Health's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avricore Health's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Avricore Health's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Avricore Health's EV-to-Revenue falls into.



Avricore Health EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Avricore Health's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=15.085/2.478
=6.09

Avricore Health's current Enterprise Value is C$15.09 Mil.
Avricore Health's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$2.48 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Avricore Health  (TSXV:AVCR) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Avricore Health's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.155/0.026
=5.96

Avricore Health's share price for today is C$0.155.
Avricore Health's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.03.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Avricore Health EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Avricore Health's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Avricore Health (TSXV:AVCR) Business Description

Traded in Other Exchanges
Address
1120 - 789 West Pender Street, Vancouver, BC, CAN, V6C 1H2
Avricore Health Inc is a Canada based company. The company is involved in the business of health data and point-of-care technologies. The Company has only one segment, being the HealthTab - Point of Care Business in Canada. The Company's revenues are generated from operating leases of the POCT system and sale of testing panels.

Avricore Health (TSXV:AVCR) Headlines

No Headlines